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Abstract
A novel sandwich immunoassay based immunochromatographic test strip (ICTS) has been 
developed for simultaneously measuring both butyrylcholinesterase (BChE) activity and the total 
amount of BChE (including inhibited and active enzyme) from 70 μLpost-exposure human plasma 
sample. The principle of this method is based on the BChE monoclonal antibody (MAb) capable 
of acting as both capture antibody and detection antibody. The BChE MAb which was 
immobilized on the test line was able to recognize both organophosphorus BChE adducts (OP-
BChE) and BChE and provided equal binding affinity, permitting detection of the total enzyme 
amount in post-exposure human plasma samples. The formed immunocomplexes on the test line 
can further be excised from the test-strip for subsequent off-line measurement of BChE activity 
using the Ellman assay. Therefore, dual biomarkers of BChE activity and phosphorylation (OP-
BChE) will be obtained simultaneously. The whole sandwich-immunoassay was performed on one 
ICTS, greatly reducing analytical time. The ICTS sensor showed excellent linear responses for 
assaying total amount of BChE and active BChE ranging from 0.22 to 3.58nM and 0.22 to 
7.17nM, respectively. Both the signal detection limits are 0.10nM. We validated the practical 
application of the proposed method to measure 124 human plasma samples from orchard workers 
and cotton farmers with long-term exposure to organophosphorus pesticides (OPs). The results 
were in highly agreement with LC/MS/MS which verified our method is extremely accurate. 
Combining the portability and rapidity of test strip and the compatibility of BChE MAb as both 
capture antibody and detection antibody, the developed method provides a baseline-free, low-cost 
and rapid tool for in-field monitoring of OP exposures.
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INTRODUCTION
Organophosphorus pesticides (OPs) are widely used for crop protection, and have 
contributed to dramatic increases in crop yields in modern agriculture (Du et al. 2011b). 
Even at relatively low levels, OPs have been linked to neurodevelopmental deficiencies in 
young children (Eskenazi et al. 2007). The toxicity of OPs is reflected by covalent binding to 
the active site of cholinesterase to inhibit the activity of the enzyme.(Fidder et al. 2002). The 
inhibition of ChE, which includes acetylcholinesterase (AChE) and butyrylcholinesterase 
(BChE), leads to an excess of acetylcholine within the nerve tissue and affects the 
transmission of the neurotransmitter (Aryal et al. 2012; Williams et al. 2007), causing 
tremors, lacrimation and bradycardia, even death (Lin et al. 2004). Therefore, development 
of simple and reliable methods for rapid detection of OPs exposures is necessary and 
essential.
Biomonitoring is an efficient approach for assessing internal dose and potential risk from 
exposure to OPs. Currently, four kinds of biomarkers have been used for detection of OPs 
exposure including assay of active enzyme (Ge et al. 2013b; Liu et al. 2005; Zhang et al. 
2014), detection of unbound OPs (Li et al. 2014; Xu et al. 2015), measurement of 
metabolites (Zhang et al. 2013; Zou et al. 2010) and quantification of phosphorylated 
enzyme adducts (OP-ChE) (Jiang et al. 2013; Johnson et al. 2015). The majority of the 
measurements for metabolites and unbound OPs are performed by gas or liquid 
chromatography coupled with mass spectrometry (GC/LC-MS) (VanDine et al. 2013; Zhu et 
al. 2015). Although these methods are sensitive and accurate, they are faced by several 
disadvantages notably use of sophisticated equipment requiring a well-trained technician to 
operate, time-consuming analysis generally performed off-site at a laboratory, lack of 
portability and concomitant delay in reporting of results (Zhang et al. 2014).
Enzyme activity in blood is a good biomarker for biomonitoring of exposure to OPs because 
it directly provides a quantitative biochemical effect of the exposure (i.e., enzyme 
inhibition). An important confounding challenge with this assay is the need of a baseline for 
each individual before a meaningful enzyme activity change can be determined. However, 
because the ChE activity baseline for individuals is generally not available, this 
measurement is often based on a population average. In addition, an individual’s level of 
ChE activity fluctuates over time. This factor creates uncertainty in historically obtained 
individual ChE activity measurements and thus may provide false results for low level 
exposure. In this regard, a baseline from individual subject is a better control than that from 
population average level served as pre-exposure baseline because the former can be obtained 
in real-time and is more accurate for calculation of ChE inhibition. According to the 
mechanism involved in phosphorylation of ChE, the inhibition event produces very stable 
enzyme complexes (OP-ChE) (Liu et al. 2008). One challenge is to find antibodies capable 
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of specifically recognizing the phosphorylated adducts due to the unique structure of OP-
ChE. The unique structure of OP-ChE is that the phosphoserine moiety is in a deep and 
narrow invagination. Current specific antibody can only recognize ChE moiety, while it is 
very hard to develop the other pair to recognize the phosphoserine moiety which is only 
several Å and deep in the gorge of ChE. We found that the same ChE antibody was able to 
be used as both capture and detecting antibody in sandwich immunoassay, which avoided to 
use the antibody to recognize the narrow invagination (Quinn 1987).
Different methods, including Michel (Δ pH) ChE assay (Ellin et al. 1973), fluorescence 
assays (Parvari et al. 1983), colorimetric Ellman assay (Ellman et al. 1961) and radioactive 
assays (Gordon et al. 1982) have been developed to measure the changes of enzyme activity 
from a basal level. Due to substantial inter-individual (e.g., age, ethnicity, sex, etc.) variation 
in the baseline of ChE, an important challenge with these assays is the need to determine 
pre-exposure ChE activity for each individual before a meaningful post-exposure change in 
activity can be determined (Gupta). Since the ChE activity baseline for individuals is 
generally not available, ChE activity measurements may provide false results for low level 
exposure such as ≤ 20% enzyme inhibition. In order to avoid the need for baseline 
measurements, we have reported baseline-free approaches to measure OPs exposures, such 
as reactivation of phosphorylated ChE (Du et al. 2012; Ge et al. 2013a), and parallel 
detection of the total enzyme and active enzyme separately (Du et al. 2011a).
Comparing to AChE, BChE is more abundant in human plasma and has higher rate of 
reaction (Aryal et al. 2012; Pantazides et al. 2014), therefore BChE was adopted as model 
analyte. In this paper, we report a simultaneous measurement of post-exposure BChE 
enzyme activity together with quantifying the total amount of BChE enzyme by 
immunoassay. Since the total concentration of enzyme (including active and inhibited) is 
measured contemporaneously with BChE activity, it can replace the need for measurement 
of subject-specific pre-exposure enzyme activity. Here, we found that anti-
butyrylcholinesterase (BChE) monoclonal antibody (MAb) is able to be used as both capture 
and detecting antibody in sandwich immunoassay. It is not necessary to adopt diverse 
antibodies for recognizing an antigen performing distinctive determinants simultaneously. 
The reason is that BChE in the native human plasma is a tetramer, consists of four identical 
subunits that can simultaneously be bound by the same monoclonal antibodies, wherein each 
binding is serving for either capturing or detection. (Haeberli 1992; Li et al. 2008; Ngamelue 
et al. 2007; Pan et al. 2009). That means each BChE protein has four epitopes which can be 
recognized by the same MAb. Our approach is based on an immunochromatographic test 
strip (ICTS) platform. Due to the advantages of portability, rapidity, and low cost, ICTS has 
become a widely used platform for in-field application (Ge et al. 2014; Kim et al. 2015; 
Quesada-Gonzalez and Merkoci 2015; Wen et al. 2017). The immobilized BChE MAb on 
the test line is able to recognize both BChE and OP-BChE in human blood samples (Sporty 
et al. 2010). Gold nanoparticle labeled anti-BChE MAb (MAb-Au) as a recognition element 
is used to quantify the total BChE. The captured BChE on the test line is then excised for 
off-line detection of BChE activity using the Ellman assay. Therefore, such an approach can 
simultaneously provide results of dual biomarkers of both enzymatic activity and 
phosphorylation, offering a more accurate and inexpensive tool for assessing exposure to 
OPs.
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2. Experimental Section
2.1 Materials and Reagents
Human butyrylcholinesterase (ab96367) (>100U), BChE monoclonal antibody (ab17246), 
goat anti-mouse IgG antibody and HRP-conjugated goat anti-mouse IgG (HRP-Ab2) was 
purchased from Abcam Inc. (Cambridge, MA). Paraoxon-ethyl was purchased from Chem 
Service, Inc. (West Chester, PA). Acetylthiocholine chloride (ATCh), 5,5′-Dithiobis (2-
nitrobenzoic acid) (DTNB), phosphate buffer saline (PBS), Tween-20, sulfuric acid, acetone, 
3,3′,5,5′-Tetramethylbenzidine (TMB), and bovine serum albumin (BSA) were purchased 
from Sigma-Aldrich (St. Louis, U.S.A.). 40nm gold nanoparticles (Au NPs) was purchased 
from nanoComposix (San Diego, CA). Microplates for enzyme-linked immunosorbent assay 
(ELISA) were purchased from Becton (Franklin Lakes, NJ). Fiber conjugate pad, fiber 
sample pad, nitrocellulose membrane and absorbent pad were obtained from Millipore 
(Bedford, MA).
2.2 Instrumentation
The separation of gold nanoparticle labeled BChE MAb (MAb-Au) was performed by 
centrifugation (Eppendorf 5417C; Eppendorf, US). The 10–140 incubator was purchased 
from Quincy Lab, Inc. The test strip was fabricated using a Guillotine Cutting System 
(BioDot LTD; Irvine, CA). The Peak Area on the test line was recorded by a portable test 
strip reader ESE-Quant GOLD (DCN Inc.; Irvine, CA). The absorbance on the test line was 
measured with a Tecan Safire2 microplate reader (Tecan, Switzerland).
2.3 Preparation of Au labeled BChE MAb
The principle of Au labeled antibody is based on electrostatic adsorption between antibody 
and gold nanoparticles. (Geoghegan and Ackerman 1977). Briefly, 0.2 M K2CO3 was added 
to 1.0 ml Au NPs (OD528 = 0.508) solution to achieve a pH of 8.5, followed by adding 30 
μL BChE MAb solution (1mg/ml) and keepingthe mixture at room temperature (about 25°C) 
for 1h after mixing it thoroughly. At pH 8.5, Au and BChE MAb showed the most effective 
conjugation (Figure S1A and S1B). Then, BSA was added to the above solution and allowed 
to stand for another 1 h. After that, the mixture was centrifuged at 10,000 rpm for 25 min 
and washed with 2 % BSA solution twice. The resultant precipitate was re-dispersed in 
deionized water which containing 2% BSA and 3% sucrose to 100 μL.
2.4 Preparation of ICTS
Scheme 1 illustrates the mechanism of the ICTS. The ICTS is comprised of four sections: 
sample pad, conjugate pad, nitrocellulose membrane (NC membrane) and absorbent pad. 
The four sections were assembled on a plastic scale board, as shown in Scheme 1. The 
conjugate pad was pretreated with pH 7.4 PBS buffer containing 2% BSA. On NC 
membrane, the Test line and Control line were prepared by dispensing BChE MAb (1 
mg/mL) and goat anti-mouse IgG antibody (0.5 mg/mL) using a BioDot BioJet BJQ 3000 
dispenser with the lining rate 1.5 μL/mm. Then the ICTS were dried overnight at room 
temperature and cut at the width of 4.0 mm using a Bio-Dot Paper Cutter module CM4000. 
Finally, the test strips were stored in Ziploc bags under dry conditions at room temperature.
Yang et al. Page 4
Biosens Bioelectron. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2.5 Preparation of OP-BChE
5 μL paraoxon-acetone solution (75 mM) (the volume of acetone less than 5% of total 
volume) was dropped into 1 mg/ml BChE solution, then diluted with PBS buffer, followed 
by standing the mixture at room temperature for 72 h. Meanwhile, BChE solution without 
paraoxon-acetone was used as control. The inhibition of BChE was measured by Ellman 
assay according to Hossain et al with a little modification. (Hossain et al. 2009).
2.6 ELISA test for the affinity of BChE MAb to BChE and OP-BChE
The affinity of BChE MAb to BChE and OP-BChE, respectively was detected by one-site 
ELISA. 50 μL BChE and OP-BChE solution with a series of different concentrations (0, 
0.72, 1.43, 2.87, 5.74 nM) were added into 96 well microplate with three replicates and 
incubated at 37°C for 2 h. After washing the wells with PBST for several times, 200 μL of 
3% BSA in PBS was added into each well and allowed to stand for 1.5 h. Thereafter, 50 μL 
of 2 μg mL−1 BChE MAb was added into each well after the plates were washed several 
times. Afterwards, 50 μL of 20,000-fold diluted HRP-Ab2 was added, and incubated for 40 
min, and re-washed. Finally, 50 μL substrate TMB was added to the respective wells and left 
to keep at room temperature for 20 min. Then, HRP reaction with TMB was stopped by 
adding 25 μL of 2.0 M H2SO4. The plate was rapidly tested on a microplate reader.
2.7 Assay procedure
70 μL sample was dropped in the sample pad and it flowed along the strip via capillary 
action. First, the sample interacted with the MAb-Au in conjugate pad to form a BChE-
MAb-Au complex. Then it continued flowing onto the NC membrane until captured by 
BChE MAb in the test line. The excess MAb-Au continued to migrate and was captured in 
the control line. The total BChE signal intensity was recorded by test strip reader. Then, the 
test line was excised and transferred into a centrifuge tube containing 100 μL ATCh solution 
and incubated for 15 min. The active BChE was measured by colorimetric analyses with 
Tecan Safire2 microplate reader after adding DTNB.
2.8 Human plasma samples
The human plasma samples were collected from workers in Washington State and in 
Pakistan who were occupationally exposed to OPs. The samples were diluted 100-fold with 
PBST (phosphate buffer saline solution containing 0.05% Tween-20) before detection. Then, 
70 μL of the diluted solution was dropped onto the sample pad to complete the test.
3. Results and Discussion
3.1 Principle of Immunoassay on ICTS
Plasma-derived BChE is a tetramer that comprises four glycoprotein subunits that are 
identical and a polyproline-rich peptide. The same monoclonal antibodies bind to different 
BChE subunit hence can be used to capture and detect BChE and OP-BChE. Our approach 
is based on a one-step ICTS for parallel measurements of active enzyme and total amount of 
enzyme from post-exposure samples. As shown in Scheme 1, both OP-BChE and active 
BChE in the sample solution first interacted with gold nanoparticles labeled with anti-BChE 
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(MAb-Au) on the conjugate pad to form OP-BChE/MAb-Au and BChE/MAb-Au 
complexes. The formed complexes kept flowing and were captured by anti-BChE MAb 
immobilized on test line to form sandwich immunocomplexes namely BChE MAb/OP-
BChE/MAb-Au and BChE MAb/BChE/MAb-Au. The excess MAb-Au continued to migrate 
and was captured in control line. The color intensity on test line was recorded by test strip 
reader. This signal reflects the total amount of BChE (including active and phosphorylated). 
Then the test line was excised from test strip and analyzed for BChE activity via the Ellman 
assay. This response is only related to the active amount of BChE in the sample. Moreover, 
phosphorylation can be calculated by subtracting active BChE from total amount of BChE. 
In comparison to the electrochemical sensing platform (Du et al. 2011a), the measurement in 
this paper is more applicable. ICTS is less expensive and easier to used compared with the 
flow injection system.
3.2 Characterization of ICTS
In our approach, having the same binding affinity of BChE-MAb to both BChE and OP-
BChE plays a crucial role to detect the total amount of BChE (including OP-BChE and 
active BChE). We verified it by both ELISA and test strip. Figure 1A shows the absorbance 
values from ELISA using a series of concentrations of the BChE and OP-BChE. The result 
showed that anti-BChE-MAb had almost equal binding affinity to BChE and OP-BChE at 
the same concentrations. Figure 1B shows the results on the test strip assay. It was observed 
that the test line had almost the same signal intensity and color density when using the same 
concentration of BChE and OP-BchE (3.44 nM). This demonstrates that the BChE-MAb can 
equally recognize BChE and OP-BChE, which is important for the principle of detection of 
total enzyme amount from post-exposure samples. Conversely, when we changed the antigen 
to AChE (3.44 nM) instead of BChE, the signal intensity on test line disappeared, which 
further demonstrated that the BChE-MAb can specifically recognize BChE and OP-BChE. 
Furthermore, PBST as a control did not show any color and the obvious signal, which 
proved that the responses came from antigen-antibody interaction as opposed to non-specific 
reaction.
3.3 Optimization of analytical parameters for BChE detection
There are three main parameters that affected the sensitivity of immunoassay: the pH of 
working solution, the volume of MAb-Au used on ICTS, and immunoreaction time of the 
ICTS. The influence of the aforementioned parameters was studied using 3.44 nM BChE. 
The pH of the working solution directly affected the stability of the antigen-antibody 
interaction. To ascertain the optimal pH of the working solution, pH was varied from 6.0 to 
9.5, and the signal from the test strip was measured. In Figure 2A, the peak area on the test 
strip increased with increasing pH and reached a maximum at pH 7.5. So pH 7.5 was used 
for the subsequent experiments. Since MAb-Au was also used as detection antibody, the 
volume of MAb-Au is another important issue for the sensitivity of immunoassay. It can be 
seen from Figure 2B that the signal intensity increased with the increase in volume of MAb-
Au within 2.0 μL and then plateaued. The immunoreaction time (i.e. time elapsed between 
applying sample to the test strip and reading response at the test line) is another important 
issue which can affect the sensitivity of immunoassay. As show in Figure 2C, the signal 
intensity increased rapidly with the increase of immunoreaction time during the first 25 min 
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and eventually stabilized, indicting completion of immunoreaction. Therefore, 25 min was 
adopted for the experiments.
3.4 Detection of total amount and activity of standard BChE
To test the performance of ICTS for simultaneous detection of the total BChE and 
uninhibited BChE, the measurements were conducted with various concentrations of 
standard BChE in PBST. As can be seen from Figure 3A, the color intensity on the test line 
weakened along with the decrease of total amount of BChE (from 1 to 8). The signal 
corresponding to the total amount of BChE was recorded by the test strip reader after 25 
min. The peak area on the test line was found to be directly proportional to the concentration 
of standard BChE. The calibration curve is y=1058.427x+843.219 which was obtained at the 
concentration range from 0.22 to 3.58 nM (Figure 3B). After detecting total amount of 
enzyme, the test line was excised and dropped into a centrifuge tube containing 100 μL 
ATCh solution and incubated for 15 min, followed by adding 100 μL DTNB. The UV 
absorbance of the mixture solution was recorded at 412nm. As shown in Figure 3C, the 
calibration curve of active BChE is y=0.1056x+0.1546 which was obtained at the 
concentration range from 0.22 to 7.17 nM. The detection limits of total amount of BChE and 
active BChE were both 0.1nM, respectively. Then the OP-BChE can be calculated by 
subtracting active BChE from total amount of BChE.
3.5 Evaluation of ICTS for measurement of OPs exposure
To demonstrate this method for quantitative detection of OPs exposure based on ICTS, 
standard BChE samples were used for this purpose. Briefly the standard BChE samples were 
firstly inhibited with different concentrations of paraoxon and tested with ICTS. Then the 
total amount of enzyme and enzyme activity were calculated from the calibration curve 
described above. As shown in Table 1, a broad percentage of phosphorylation (9–99%) was 
achieved by varying the concentrations of paraoxon (0.002–0.2 mg kg−1). As expected the 
BChE activity decreased accordingly. Those results were further compared with the Ellman 
assay, the relative deviations were ± 5% and the correlation coefficient is 0.9983 (Fig. S2), 
indicating that this approach is reliable and accurate.
3.6 Validation of ICTS with human blood samples
To further validate the practical application of the proposed method, blood collected from 
orchard workers in Washington State (89 samples), and chlorpyrifos manufacturing workers 
and cotton farmers in Pakistan (35 samples) with long-term exposure to OPs were measured. 
Before detection, those samples were diluted 100-fold with PBST. Percent phosphorylation 
was also determined independently using an LC/MS/MS procedure that directly measures 
the BChE-OP adduct (Riutta 2012). As shown in Figure 4, these samples covered a wide 
range of % phosphorylation, between 0–92%. Due to the complexity of human plasma, 
ICTS might have the possibility of false positive results. However, the mean absolute 
difference between the ICTS and LC/MS/MS measurements was 7 % (range 0–47%), and 
the agreement between the two methods was excellent (Pearson correlation 0.85, p<0.001). 
We believe that the proposed ICTS method will offer a more inexpensive tool for rapid and 
accurate monitoring of exposure to OPs.
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4. Conclusion
In summary, we have developed a simple immunochromatographic test strip capable of 
detecting OPs exposures in human blood samples. This approach is based on simultaneous 
determination of enzyme activity and total amount of enzyme in one post-exposure sample. 
The novelty of this method includes: (1) the anti-BChE monoclonal antibody which binds 
both BChE and OP-BChE, which is a breakthrough for the sandwich immunoassay of total 
BChE; (2) a single test line can provide results for both BChE activity and total amount of 
BChE. The proposed method offers a baseline-free, low-cost, rapid and accurate tool for in-
field assessing of OP exposures.
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Figure 1. 
(A) ELISA of the binding affinity of BChE MAb to BChE and OP-BChE. (B) Results of 
different samples on test strip reader analysis. The inset shows the visual color results on the 
test strip.
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Figure 2. 
Optimization of parameters of the test strip. (A) Effect of the pH of working solution on 
detection of total enzyme. (B) Effect of the volume of MAb-Au on detection of total 
enzyme. (C) Effect of immunoreaction time on the test strip.
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Figure 3. 
(A) Detection of different concentrations of total amount BChE in PBST with ICTS. 
Concentrations of BChE from 1–8 were 14.34, 7.17, 3.58, 1.80, 0.90, 0.45, 0.22, 0nM. (B) 
The calibration curve of the total amount of enzyme recorded by strip reader. (C) The 
calibration curve of active enzyme recorded by colorimetric analysis.
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Figure 4. 
Comparison of % phosphorylation with human plasma sample by ITCS and LC/MS/MS 
methods.
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Scheme 1. 
Illustration of the principle of one-step ICTS
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